Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-20
EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report
Abstract
We present the case of advanced lung cancer female patients after histological and molecular diagnostic procedures, treated with EGFR tyrosine kinase inhibitor, erlotinib.
Keywords: case reportnon-small lung cancererlotinib